Navigation Links
Symposium to provide forum for best pre-clinical and translational bone research
Date:1/10/2011

The 1st IOF-ESCEO Pre-Clinical Symposium, a new forum for the best pre-clinicaland translational science in bone biology, is to be held from March 22-23, 2011, immediately preceding the European Congress on Osteoporosis and Osteoarthritis (ECCEO11-IOF) in Valencia. The Symposium will be chaired by Gerard Karsenty, Professor and Chair, Genetics & Development, Columbia University MC one of the world's leading scientists from the bone biology arena. All programme information as well as online registration and abstract submission (January14) is available at http://www.ecceo11-iof.org

The Symposium is aimed at scientists engaged in pre-clinical research in osteoporosis, osteoarthritis and related metabolic bone diseases. In order to support attendance by young researchers, the organizers are offering low registration rates* (only 150 euro) and awards (250 euro) for abstracts selected for oral presentation. Seven hours will be dedicated solely to oral presentations. In addition there will be 'Meet the faculty' sessions of interest to young researchers.

The programme includes the following invited lectures:

  • Inflammation and bone development (E. Wagner)
  • Periarticular bone remodeling ( J.P. David)
  • The osteoclast in tumoral bone involvement (A. Teti)
  • Pathophysiology of tumoral bone disease (Ph. Clzardin)
  • Skeletal stem cell: Basic biology and clinical applications (M. Kassem)
  • Post-natal, microvascular progenitors for bone and other mesoderm derivatives (P. Bianco)
  • Control of bone formation (T. Schinke)
  • Regulation of bone mass by serotonin (G. Karsenty)

Key dates: Abstracts: January 14, 2011 Pre-registration closes March 7, 2011

* the 1st IOF-ESCEO Pre-Clinical Symposium is free for registrants of the European Congress on Osteoporosis & Osteoarthritis. Visit http://www.ecceo11-iof.org


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Oil spill symposium to convene scientists, media, policymakers and community leaders
2. Graduate physics students wins top honors in superconductivity symposium
3. Symposium marks milestones in honey bee management, research
4. CTRC-AACR to hold 33rd Annual San Antonio Breast Cancer Symposium
5. Symposium in Vietnam to discuss integrated approach to defeating diarrheal disease
6. Abstracts for the EORTC-NCI-AACR Symposium in Berlin go up online on Friday, Oct. 29
7. 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
8. Stem Cells and International Stem Cell Symposium present annual stem cells award
9. Military medicine symposium to explore regenerative medicine, behavioral health
10. Sutherland and Berglass to keynote USU-HJF Military Medicine Symposium
11. University at Buffalo symposium on in silico methods, high throughput screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... about the prevalence of antibiotic-resistant illness, Case Western ... to disabling disease: blocking bacteria,s access to iron ... bacterial siderophore, a small molecule, captures iron from ... as well as how the body launches ... findings appear in a recent edition of ...
(Date:7/9/2014)... may be able to cope with the rising salinity of ... Arctic today is best known for its tundra and polar ... to 38 million years ago during what is known as ... huge temperate forest with brackish water, home to a variety ... and giant tortoises. Much of what is known about the ...
(Date:7/9/2014)... but often can be defeated with antibiotics and then ... Now, scientists have built a new weapon against such pathogens ... journal ACS Applied Materials & Interfaces , their study ... them than medicine alone. , David Leong, Jianping Xie and ... undetectable in the human body or in places that antibiotics ...
Breaking Biology News(10 mins):Bacteria hijack plentiful iron supply source to flourish 2Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3
... compound found in green tea shows great promise for ... tumors and a deadly congenital disease. The discovery ... Dr. Thomas Smith at The Donald Danforth Plant Science ... Philadelphia. Their findings are published in the recent article, ...
... A research team led by St. Jude Children,s ... for treatment of the childhood eye tumor retinoblastoma. Their ... cancer,s cellular origins are as scrambled as the developmental ... cancers that resemble a particular type of cell, researchers ...
... New research suggests that blood stem cells can be involved ... caused by the abnormal proliferation of mature cells. The study, ... the journal Cancer Cell , may guide future strategies ... CLL is a cancer of a type of mature ...
Cached Biology News:Researchers demonstrate green tea is effective in treating genetic disorder and types of tumors 2Childhood eye tumor made up of hybrid cells with jumbled development 2Childhood eye tumor made up of hybrid cells with jumbled development 3Stem cells central to pathogenesis of mature lymphoid tumors 2
(Date:1/15/2014)... Automotive, a group of car dealerships headquartered in ... Center and offering free oil change coupons for participation in ... 18 at the Bill Jacobs Cadillac and Chevrolet location from ... )  The Bill Jacobs Auto annual blood ...
(Date:1/15/2014)... 15, 2014 Cynvenio, a cancer diagnostics ... the genomic analysis of tumor cells in the bloodstream, ... web-based cancer decision support application powered by CollabRx, Inc. ... ClearID™ genomic test, Therapy Finder will provide breast cancer ...
(Date:1/15/2014)... A study has been launched to test whether ... could help to tackle the problem of obesity.  This unique ... surgery based in Stowmarket) and academics at University Campus Suffolk ... technology, which is inspired by equipment used to collect data ...
(Date:1/15/2014)... DTS Language Services, Inc . is ... for Life Science organizations who need document translations. Clients ... of their documents in advance with a selection of nearly ... translations, often a critical factor in clinical and scientific fields, ...
Breaking Biology Technology:Join the Bill Jacobs Auto blood drive and receive a free oil change 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2
... (Nasdaq: FOLD ) today announced it plans to initiate ... drug in development for the treatment of Pompe Disease. ... pharmacokinetics of AT2220 in muscle tissue in healthy adult subjects. ... to Amicus, proposal for the Phase 1 study and subsequently ...
... PARIS, September 30 , ... to Achieve Similar, Well,Tolerated Glycemic Control Versus Lantus(R) , ... ) announced today results of a,head-to-head study providing further evidence ... [rDNA] injection) compared,to twice-daily insulin detemir. The study was presented ...
... John McPherson, Platform Leader, Cancer Genomics and High-Throughput Screening, ... Institute for Cancer Research (OICR) led a team of ... NEBNext(TM) DNA Sample Prep Reagents for use with OICR,s ... evaluation, "We are constantly striving for the best quality ...
Cached Biology Technology:Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 2Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 3Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease 4Superior Efficacy-dose Ratio for Lantus(R) Over detemir 2Superior Efficacy-dose Ratio for Lantus(R) Over detemir 3Superior Efficacy-dose Ratio for Lantus(R) Over detemir 4Superior Efficacy-dose Ratio for Lantus(R) Over detemir 5Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing 2
Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...
Request Info...
... labware. Waterproof, moisture-proof film prevents sample ... be folded repeatedly and twisted around ... at 21C (70F), wrapping film increases ... removed, film only partially returns to ...
...
Biology Products: